Table 1 Baseline characteristics of patients with high and patients with low depressive symptoms score on Day 8.

From: Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms

 

High score of depressive symptoms (N = 27)

Low score of depressive symptoms (N = 143)

P-value

Age (years), median (IQs)

67 (58–73)

67 (61–78)

0.54

Female, n (%)

7 (25.9)

59 (41.3)

0.13

Hypertension, n (%)

21 (77.8)

107 (74.8)

0.74

Diabetes mellitus, n (%)

9 (33.3)

36 (25.2)

0.38

Atrial fibrillation, n (%)

10 (37.0)

40 (28.0)

0.34

Myocardial infarction, n (%)

4 (14.8)

16 (11.2)

0.60

Previous stroke or TIA, n (%)

3 (11.1)

15 (10.5)

0.92

Prestroke cognitive decline, n (%)a

5/22 (22.7)

9/118 (7.6)

0.03

NIHSS score on admission, n (%)

7 (4–13)

7 (5–14)

0.36

Stroke etiology

  

0.40

 Large vessel disease, n (%)

5 (18.5)

34 (23.7)

 

 Small vessel disease, n (%)

0 (0)

10 (7.0)

 

Cardio-embolic, n (%)

9 (33.3)

42 (29.4)

 

Other, n (%)

0 (0)

5 (3.5)

 

Undermined, n (%)

13 (48.2)

52 (36.4)

 

Intravenous thrombolysis, n (%)

14 (51.8)

81 (56.6)

0.64

Mechanical thrombectomy, n (%)

4 (14.8)

39 (27.3)

0.17

In-hospital pneumonia, n (%)

3 (11.1)

7 (4.9)

0.21

White blood cells count, ×103/µL, median (IQs)

8.7 (7.1–10.0)

7.8 (6.6–9.4)

0.13

Lymphocyte, ×103/µL, median (IQs)

1.8 (1.5–2.3)

1.8 (1.4–2.2)

0.65

Monocyte, ×103/µL, median (IQs)

0.7 (0.7–1.1)

0.8 (0.6–0.9)

0.44

  1. aData available for 140 patients.